Your browser doesn't support javascript.
loading
A Multicenter Phase II Study of Pazopanib in Patients with Unresectable Dermatofibrosarcoma Protuberans.
Delyon, Julie; Porcher, Raphael; Battistella, Maxime; Meyer, Nicolas; Adamski, Henri; Bertucci, François; Guillot, Bernard; Jouary, Thomas; Leccia, Marie-Thérèse; Dalac, Sophie; Mortier, Laurent; Ghrieb, Zineb; Da Meda, Laetitia; Vicaut, Eric; Pedeutour, Florence; Mourah, Samia; Lebbe, Celeste.
Afiliación
  • Delyon J; Team 1, HIPI, INSERM U976, Université de Paris, Paris, France; Department of Dermatology, Hôpital Saint-Louis AP-HP, Paris, France. Electronic address: Julie.delyon@aphp.fr.
  • Porcher R; CRESS-UMR1153, INSERM, INRA, Université de Paris, Paris, France; Centre d'Épidémiologie Clinique, Hôpital Hôtel-Dieu, AP-HP, Paris, France.
  • Battistella M; INSERM U976, Université de Paris, Paris, France; Pathology department, Hopital Saint-Louis AP-HP, Paris, France.
  • Meyer N; Dermatologie, Institut Universitaire du Cancer et CHU de Toulouse, Toulouse, France; INSERM UMR 1037-CRCT, Toulouse, France.
  • Adamski H; Department of Dermatology, Rennes University Hospital, Rennes, France.
  • Bertucci F; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
  • Guillot B; Department of Dermatology, Montpellier University Hospital, Montpellier, France.
  • Jouary T; Department of Dermatology, Hôpital François Mitterrand, Pau, France.
  • Leccia MT; Department of Dermatology, Grenoble University Hospital, Grenoble, France.
  • Dalac S; Department of Dermatology, CHU Dijon Bourgogne, Dijon, France.
  • Mortier L; Department of Dermatology, INSERM U1189, CHU Lille, University of Lille, Lille, France.
  • Ghrieb Z; Centre d'Investigations Cliniques (CIC-1427), Hôpital Saint-Louis AP-HP, Paris, France.
  • Da Meda L; Department of Dermatology, Hôpital Saint-Louis AP-HP, Paris, France.
  • Vicaut E; Unité de Recherche Clinique, Hôpital Fernand Widal, Paris, France.
  • Pedeutour F; Laboratory of Solid Tumors Genetics, Institute for Research on Cancer and Aging of Nice (IRCAN), CNRS UMR 7284/INSERM U1081, Nice University Hospital affiliated, Nice University Côte d'Azur, Nice, France.
  • Mourah S; INSERM U976, Laboratoire de Pharmacogénomique, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France.
  • Lebbe C; Team 1, HIPI, INSERM U976, Université de Paris, Paris, France; Department of Dermatology, Hôpital Saint-Louis AP-HP, Paris, France.
J Invest Dermatol ; 141(4): 761-769.e2, 2021 04.
Article en En | MEDLINE | ID: mdl-32956651
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirimidinas / Neoplasias Cutáneas / Sulfonamidas / Dermatofibrosarcoma / Inhibidores de Proteínas Quinasas / Indazoles Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Invest Dermatol Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirimidinas / Neoplasias Cutáneas / Sulfonamidas / Dermatofibrosarcoma / Inhibidores de Proteínas Quinasas / Indazoles Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Invest Dermatol Año: 2021 Tipo del documento: Article